Published in Pediatr Nephrol on December 23, 2009
Pharmacokinetics of rituximab in a pediatric patient with therapy-resistant nephrotic syndrome. Pediatr Nephrol (2015) 2.05
Rituximab in children with resistant idiopathic nephrotic syndrome. J Am Soc Nephrol (2012) 1.83
Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome. Pediatr Nephrol (2013) 1.63
Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial. Clin J Am Soc Nephrol (2011) 1.62
Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report. Clin J Am Soc Nephrol (2010) 1.51
Rituximab treatment combined with methylprednisolone pulse therapy and immunosuppressants for childhood steroid-resistant nephrotic syndrome. Pediatr Nephrol (2014) 1.46
Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO. Pediatr Nephrol (2012) 1.45
Treatment outcome of late steroid-resistant nephrotic syndrome: a study by the Midwest Pediatric Nephrology Consortium. Pediatr Nephrol (2013) 1.39
New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome. Pediatr Nephrol (2011) 1.19
Rituximab therapy in nephrotic syndrome: implications for patients' management. Nat Rev Nephrol (2013) 1.18
Recent progress in the pathophysiology and treatment of FSGS recurrence. Am J Transplant (2013) 1.13
Childhood nephrotic syndrome--current and future therapies. Nat Rev Nephrol (2012) 1.02
Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO. Pediatr Nephrol (2012) 1.02
Colitis associated with biological agents. World J Gastroenterol (2012) 1.00
Fulminant viral myocarditis after rituximab therapy in pediatric nephrotic syndrome. Pediatr Nephrol (2013) 0.99
Rituximab for refractory cases of childhood nephrotic syndrome. Pediatr Nephrol (2011) 0.98
The factors that may predict response to rituximab therapy in recurrent focal segmental glomerulosclerosis: a systematic review. J Transplant (2011) 0.97
Chapter 3: Steroid-sensitive nephrotic syndrome in children. Kidney Int Suppl (2011) (2012) 0.95
Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome. Pediatr Nephrol (2012) 0.92
Is rituximab effective in childhood nephrotic syndrome? Yes and no. Pediatr Nephrol (2013) 0.92
Treatment of recurrent focal segmental glomerulosclerosis in pediatric kidney transplant recipients: effect of rituximab. J Transplant (2011) 0.90
The efficacy and safety of rituximab in treating childhood refractory nephrotic syndrome: a meta-analysis. Sci Rep (2015) 0.90
Short-term efficacy of rituximab versus tacrolimus in steroid-dependent nephrotic syndrome. Pediatr Nephrol (2011) 0.89
Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children. Clin J Am Soc Nephrol (2015) 0.88
Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy. Clin Exp Nephrol (2015) 0.85
Rituximab in idiopathic nephrotic syndrome: does it make sense? Pediatr Nephrol (2013) 0.84
Rituximab in adult patients with multi-relapsing/steroid-dependent minimal change disease and focal segmental glomerulosclerosis: a report of 5 cases. Wien Klin Wochenschr (2013) 0.82
CD19 + CD23+ B cells, CD4 + CD25+ T cells, E-selectin and interleukin-12 levels in children with steroid sensitive nephrotic syndrome. Ital J Pediatr (2013) 0.80
Should we consider MMF therapy after rituximab for nephrotic syndrome? Pediatr Nephrol (2011) 0.79
Cyclosporine A for the treatment of refractory nephrotic syndrome with renal dysfunction. Exp Ther Med (2013) 0.79
Rituximab for nephrotic syndrome in children. Clin Exp Nephrol (2016) 0.78
Two-year follow-up of a prospective clinical trial of cyclosporine for frequently relapsing nephrotic syndrome in children. Clin J Am Soc Nephrol (2012) 0.78
Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome. Pediatr Nephrol (2015) 0.78
Update on the treatment of focal segmental glomerulosclerosis in renal transplantation. World J Transplant (2016) 0.78
Rituximab for troublesome cases of childhood nephrotic syndrome. World J Clin Pediatr (2014) 0.78
T Lymphocyte Activation Markers as Predictors of Responsiveness to Rituximab among Patients with FSGS. Clin J Am Soc Nephrol (2016) 0.77
Indications for use and safety of rituximab in childhood renal diseases. Pediatr Nephrol (2012) 0.77
Rituximab Treatment for Nephrotic Syndrome in Children. Curr Pediatr Rep (2015) 0.76
Treatment of steroid-resistant pediatric nephrotic syndrome. Korean J Pediatr (2011) 0.75
The efficacy of rituximab in adult frequently relapsing minimal change disease. Clin Kidney J (2016) 0.75
Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol. BMJ Open (2017) 0.75
Sustained complete remission of steroid- and cyclophosphamide-resistant minimal-change disease with a single course of rituximab therapy. Clin Kidney J (2014) 0.75
Single dose of rituximab in children with steroid-dependent minimal change nephrotic syndrome. Biomed Rep (2016) 0.75
Kinetics of Rituximab Excretion into Urine and Peritoneal Fluid in Two Patients with Nephrotic Syndrome. Case Rep Nephrol (2017) 0.75
Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatr Nephrol (2008) 2.64
Focal and segmental glomerulosclerosis: definition and relevance of a partial remission. J Am Soc Nephrol (2005) 2.25
Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome. Pediatr Nephrol (2005) 2.08
Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment. N Engl J Med (2006) 1.55
Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children. Pediatr Nephrol (2009) 1.49
Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated. Nephrol Dial Transplant (2007) 1.41
Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk? Autoimmun Rev (2008) 1.37
Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy. Pediatr Nephrol (2004) 1.37
Progressive multifocal leucoencephalopathy in the rheumatic diseases: assessing the risks of biological immunosuppressive therapies. Ann Rheum Dis (2008) 1.22
Rituximab in patients with the steroid-resistant nephrotic syndrome. N Engl J Med (2007) 1.15
Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis. Am J Transplant (2007) 1.05
Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab. Transpl Int (2007) 1.04
Rituximab for refractory focal segmental glomerulosclerosis. Pediatr Nephrol (2007) 1.00
Rituximab therapy for steroid-dependent minimal change nephrotic syndrome. Pediatr Nephrol (2006) 1.00
Recurrent nephrotic syndrome after transplantation: early treatment with plasmaphaeresis and cyclophosphamide. Pediatr Nephrol (1993) 0.99
Does rituximab treat recurrent focal segmental glomerulosclerosis post-renal transplantation? Pediatr Nephrol (2006) 0.98
B cell depletion therapy for 19 patients with refractory systemic lupus erythematosus. Arch Dis Child (2007) 0.90
Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab. Int Urol Nephrol (2008) 0.87
Is there a role for rituximab in the treatment of idiopathic childhood nephrotic syndrome? Pediatr Nephrol (2007) 0.82
The clinical effectiveness and cost-effectiveness of treatments for children with idiopathic steroid-resistant nephrotic syndrome: a systematic review. Health Technol Assess (2007) 0.82
Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment. Int J Hematol (2006) 0.78
Role of mycophenolate mofetil in remission maintenance after a successful response to rituximab. Pediatr Nephrol (2008) 0.76
Acute hyponatremia related to intravenous fluid administration in hospitalized children: an observational study. Pediatrics (2004) 5.02
Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N Engl J Med (2009) 4.96
A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. Am J Psychiatry (2011) 3.71
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Kidney Int (2014) 3.40
Issues in the mentor-mentee relationship in academic medicine: a qualitative study. Acad Med (2009) 3.26
Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc Natl Acad Sci U S A (2003) 2.79
Mortality in schizophrenia: a measurable clinical endpoint. J Psychopharmacol (2010) 2.65
Tomato aromatic amino acid decarboxylases participate in synthesis of the flavor volatiles 2-phenylethanol and 2-phenylacetaldehyde. Proc Natl Acad Sci U S A (2006) 2.30
UNSCEAR 2013 Report. Volume I: Report to the General Assembly, Annex A: Levels and effects of radiation exposure due to the nuclear accident after the 2011 great east-Japan earthquake and tsunami. J Radiol Prot (2014) 2.26
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis (2012) 2.21
Renovascular hypertension in children. Lancet (2008) 2.17
The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int (2010) 2.14
Suicide and schizophrenia: a systematic review of rates and risk factors. J Psychopharmacol (2010) 2.11
Acute renal failure due to obstructive uric acid stones associated with acute gastroenteritis. Pediatr Nephrol (2009) 2.09
Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome. Pediatr Nephrol (2005) 2.08
Induction of anesthesia and insertion of a laryngeal mask airway in the prone position for minor surgery. Anesth Analg (2002) 1.99
Cerebral sinovenous thrombosis and idiopathic nephrotic syndrome in childhood: report of four new cases and review of the literature. Eur J Pediatr (2006) 1.99
Teaching practicing surgeons critical appraisal skills with an Internet-based journal club: A randomized, controlled trial. Surgery (2004) 1.93
Severe hypertension in children and adolescents: pathophysiology and treatment. Pediatr Nephrol (2008) 1.90
Febrile urinary tract infections in children. N Engl J Med (2011) 1.86
A novel equation to estimate glomerular filtration rate using beta-trace protein. Clin Chem (2007) 1.85
Genotype-phenotype correlations in alternating hemiplegia of childhood. Neurology (2014) 1.82
Agreement between measured and self-reported weight in older women. Results from the British Women's Heart and Health Study. Age Ageing (2002) 1.78
Doxycycline in the treatment of human onchocerciasis: Kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms. Microbes Infect (2003) 1.72
B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus. Arthritis Rheum (2005) 1.71
Improved renal survival in Japanese children with IgA nephropathy. Pediatr Nephrol (2008) 1.67
Maintenance therapy with mycophenolate mofetil after rituximab in pediatric patients with steroid-dependent nephrotic syndrome. Pediatr Nephrol (2011) 1.67
Finance. New Medicare cuts will force hospitals to plug major revenue leak. Hosp Health Netw (2010) 1.66
Simultaneous sequencing of 24 genes associated with steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol (2013) 1.64
Randomised, double-blind, placebo-controlled trial to determine whether steroids reduce the incidence and severity of nephropathy in Henoch-Schonlein Purpura (HSP). Arch Dis Child (2013) 1.63
Neurological features of epilepsy, ataxia, sensorineural deafness, tubulopathy syndrome. Dev Med Child Neurol (2013) 1.61
Prospective 5-year follow-up of cyclosporine treatment in children with steroid-resistant nephrosis. Pediatr Nephrol (2013) 1.60
Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis. PLoS Pathog (2006) 1.57
Assessing contractile ability of the quadriceps muscle using ultrasound imaging. Muscle Nerve (2010) 1.57
A deep intronic mutation in the SLC12A3 gene leads to Gitelman syndrome. Pediatr Res (2009) 1.57
Identification of FOXP3-negative regulatory T-like (CD4(+)CD25(+)CD127(low)) cells in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Clin Immunol (2011) 1.57
Hemolytic uremic syndrome associated with invasive pneumococcal disease: the United kingdom experience. J Pediatr (2007) 1.56
Morbidity in children with frequently relapsing nephrosis: 10-year follow-up of a randomized controlled trial. Pediatr Nephrol (2014) 1.53
EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation. Ann Rheum Dis (2010) 1.51
Saquinavir in steroid-dependent and -resistant nephrotic syndrome: a pilot study. Nephrol Dial Transplant (2012) 1.51
Antibiotics for treating lower urinary tract infection in children. Cochrane Database Syst Rev (2012) 1.50
Intravenous immunoglobulin as rescue therapy for BK virus nephropathy. Pediatr Transplant (2008) 1.50
Chronic kidney disease in children following lung and heart-lung transplantation. Pediatr Transplant (2008) 1.49
Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children. Pediatr Nephrol (2009) 1.49
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in acute pyelonephritis and renal scarring. Pediatr Res (2003) 1.47
Rituximab treatment combined with methylprednisolone pulse therapy and immunosuppressants for childhood steroid-resistant nephrotic syndrome. Pediatr Nephrol (2014) 1.46
Dense B cell infiltrates in paediatric renal transplant biopsies are predictive of allograft loss. Pediatr Transplant (2008) 1.43
Electronic prescribing reduced prescribing errors in a pediatric renal outpatient clinic. J Pediatr (2007) 1.43
Biopsy timing and Oxford classification variables in childhood/adolescent IgA nephropathy. Pediatr Nephrol (2014) 1.43
Angioplasty for renovascular hypertension in children: 20-year experience. Pediatrics (2006) 1.43
Urinary tract infections in children and the risk of ESRF. Acta Paediatr (2011) 1.42
Chronic renal disease is more prevalent in patients with hemolytic uremic syndrome who had a positive history of diarrhea. Kidney Int (2010) 1.41
Experiments in payment. Hosp Health Netw (2008) 1.41
Microbiologic assessment of multidose Restylane for facial augmentation. Arch Facial Plast Surg (2009) 1.40
Treatment strategies for Henoch-Schönlein purpura nephritis by histological and clinical severity. Pediatr Nephrol (2011) 1.39
Caregiver attitudes towards gastrostomy removal after renal transplantation. Pediatr Transplant (2005) 1.39
The semantic smart laboratory: a system for supporting the chemical eScientist. Org Biomol Chem (2004) 1.39
Regulations. Federal eyes trained on self-referral rules. Hosp Health Netw (2007) 1.39
Adherence to waiting-time targets for pediatric nephrology clinic referrals. Pediatr Nephrol (2009) 1.39
Antipsychotics and abnormal liver function tests: systematic review. Clin Neuropharmacol (2012) 1.39
Renal biopsy criterion in children with asymptomatic constant isolated proteinuria. Nephrol Dial Transplant (2012) 1.38
Whacked by RAC. Hosp Health Netw (2014) 1.38
Pediatric reference intervals for immunoglobulin G and its subclasses with Siemens immunonephelometric assays. Clin Biochem (2010) 1.38
Progression of chronic renal failure in children with dysplastic kidneys. Pediatr Nephrol (2007) 1.36
Estimating glomerular filtration rate in kidney transplantation: a comparison between serum creatinine and cystatin C-based methods. J Am Soc Nephrol (2005) 1.36
Getting antimalarials on target: impact of national roll-out of malaria rapid diagnostic tests on health facility treatment in three regions of Tanzania. Trop Med Int Health (2013) 1.35
Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific [18F]-labeled isatin sulfonamide. Proc Natl Acad Sci U S A (2009) 1.34
Lateral ectopic thyroid goiter with a normally located thyroid. Thyroid (2010) 1.33
Age, gender, and body length effects on reference serum creatinine levels determined by an enzymatic method in Japanese children: a multicenter study. Clin Exp Nephrol (2011) 1.31
Bis(4-carbamoylpiperidinium) biphenyl-4,4'-disulfonate. Acta Crystallogr Sect E Struct Rep Online (2010) 1.30
Linking source and effect: resuspended soil lead, air lead, and children's blood lead levels in Detroit, Michigan. Environ Sci Technol (2013) 1.30
A dedicated spectrometer for dissolution DNP NMR spectroscopy. Phys Chem Chem Phys (2010) 1.29
HNF1B mutations associate with hypomagnesemia and renal magnesium wasting. J Am Soc Nephrol (2009) 1.29
Neonatal urinary ascites secondary to urinary bladder rupture. J Pediatr Urol (2008) 1.29
4-Chloro-anilinium 2-carb-oxy-4,5-dichloro-benzoate. Acta Crystallogr Sect E Struct Rep Online (2009) 1.27
The effect of tobacco ingredients on smoke chemistry. Part I: Flavourings and additives. Food Chem Toxicol (2004) 1.24
Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial. Clin J Am Soc Nephrol (2006) 1.24
Association between clinical risk factors and progression of chronic kidney disease in children. Clin J Am Soc Nephrol (2010) 1.20
First-generation antipsychotic long-acting injections v. oral antipsychotics in schizophrenia: systematic review of randomised controlled trials and observational studies. Br J Psychiatry Suppl (2009) 1.20
Attitudes of patients and mental health staff to antipsychotic long-acting injections: systematic review. Br J Psychiatry Suppl (2009) 1.19
Patients with autosomal dominant polycystic kidney disease hyperfiltrate early in their disease. Am J Kidney Dis (2004) 1.19
Schimke immunoosseous dysplasia: suggestions of genetic diversity. Hum Mutat (2007) 1.19
Renal biopsies in children: current practice and audit of outcomes. Nephrol Dial Transplant (2009) 1.19
Comparison of long-term numerical and experimental total knee replacement wear during simulated gait loading. J Biomech (2006) 1.17
Validity of the Oxford classification of IgA nephropathy in children. Pediatr Nephrol (2011) 1.17
Isopropyl-aminium 2-carb-oxy-4,5-di-chloro-benzoate. Acta Crystallogr Sect E Struct Rep Online (2009) 1.16
Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease. FASEB J (2011) 1.16
Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine. Pediatr Nephrol (2010) 1.15
International variation in neighborhood walkability, transit, and recreation environments using geographic information systems: the IPEN adult study. Int J Health Geogr (2014) 1.14
Estimating GFR using serum beta trace protein: accuracy and validation in kidney transplant and pediatric populations. Kidney Int (2009) 1.14
Pediatric urolithiasis: experience at a tertiary care pediatric hospital. Can Urol Assoc J (2008) 1.13
Doxycycline improves filarial lymphedema independent of active filarial infection: a randomized controlled trial. Clin Infect Dis (2012) 1.12
Atypical Pneumocystis jiroveci pneumonia with multiple nodular granulomas after rituximab for refractory nephrotic syndrome. Pediatr Nephrol (2012) 1.12
Development of a mentorship strategy: a knowledge translation case study. J Contin Educ Health Prof (2008) 1.12
Altered electroretinograms in patients with KCNJ10 mutations and EAST syndrome. J Physiol (2011) 1.12
Biologic therapy in primary systemic vasculitis of the young. Rheumatology (Oxford) (2009) 1.12